Therapeutics company
AI-generated insights about Diametica Therapeutics from various financial sources
A 10% owner with a previously successful track record purchased over $11 million worth of stock, suggesting a high level of confidence in the company's future.
A 10% owner with a previously successful track record purchased over $11 million worth of stock, suggesting a high level of confidence in the company's future.